Walleye Trading’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,724
| Closed | -$4.83M | – | 4257 |
|
|
2026
Q1 | $4.34M | Sell |
4,724
-24,776
| -84% | -$25.1M | 0.01% | 1215 |
|
|
2025
Q4 | $31.7M | Sell |
29,500
-4,474
| -13% | -$4.28M | 0.05% | 423 |
|
|
2025
Q3 | $25.9M | Sell |
33,974
-1,321
| -4% | -$983K | 0.04% | 486 |
|
|
2025
Q2 | $27.5M | Buy |
35,295
+22,900
| +185% | +$17.8M | 0.05% | 409 |
|
|
2025
Q1 | $10.2M | Sell |
12,395
-98,423
| -89% | -$81.9M | 0.02% | 712 |
|
|
2024
Q4 | $85.6M | Sell |
110,818
-9,968
| -8% | -$8.25M | 0.18% | 96 |
|
|
2024
Q3 | $107M | Buy |
120,786
+21,346
| +21% | +$19.2M | 0.22% | 62 |
|
|
2024
Q2 | $90M | Sell |
99,440
-23,673
| -19% | -$18.9M | 0.21% | 77 |
|
|
2024
Q1 | $95.8M | Buy |
123,113
+27,590
| +29% | +$19.6M | 0.2% | 70 |
|
|
2023
Q4 | $55.7M | Buy |
95,523
+86,376
| +944% | +$50.4M | 0.12% | 138 |
|
|
2023
Q3 | $4.91M | Buy |
+9,147
| New | +$4.71M | 0.01% | 1140 |
|
|
2022
Q3 | – | Sell |
-42
| Closed | -$13.3K | – | 5301 |
|
|
2022
Q2 | $14K | Buy |
+42
| New | +$12.6K | ﹤0.01% | 4584 |
|
|
2022
Q1 | – | Sell |
-34,498
| Closed | -$8.88M | – | 5643 |
|
|
2021
Q4 | $9.53M | Buy |
34,498
+30,718
| +813% | +$7.79M | 0.03% | 633 |
|
|
2021
Q3 | $873K | Buy |
+3,780
| New | +$933K | ﹤0.01% | 2356 |
|
|
2019
Q3 | – | Sell |
-9,806
| Closed | -$1.09M | – | 4236 |
|
|
2019
Q2 | $1.09M | Buy |
+9,806
| New | +$1.15M | 0.01% | 1525 |
|
|
2018
Q2 | – | Sell |
-42,625
| Closed | -$3.5M | – | 4752 |
|
|
2018
Q1 | $3.3M | Buy |
42,625
+24,540
| +136% | +$1.98M | 0.02% | 789 |
|
|
2017
Q4 | $1.53M | Buy |
+18,085
| New | +$1.54M | 0.01% | 1541 |
|
|
2016
Q1 | – | Sell |
-12,107
| Closed | -$916K | – | 5607 |
|
|
2015
Q4 | $1.02M | Buy |
+12,107
| New | +$1M | 0.01% | 1246 |
|
|
2015
Q1 | – | Sell |
-42,128
| Closed | -$3M | – | 4303 |
|
|
2014
Q4 | $2.91M | Buy |
42,128
+37,449
| +800% | +$2.53M | 0.03% | 514 |
|
|
2014
Q3 | $303K | Buy |
+4,679
| New | +$296K | ﹤0.01% | 1736 |
|
|
2014
Q1 | – | Sell |
-15,162
| Closed | -$846K | – | 3747 |
|
|
2013
Q4 | $773K | Sell |
15,162
-38,556
| -72% | -$1.93M | 0.01% | 1275 |
|
|
2013
Q3 | $2.7M | Sell |
53,718
-3,451
| -6% | -$181K | 0.03% | 444 |
|
|
2013
Q2 | $2.81M | Buy |
+57,169
| New | +$3.11M | 0.03% | 461 |
|
Other funds holding LLY
Walleye Trading's LLY Position: Q2 2026 in Review
Walleye Trading sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 4,724 shares — an estimated $4.83M sold.
Walleye Trading first reported a position in LLY in Q2 2013 and held it in 23 quarters. The position peaked at $107M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Walleye Trading reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 4,724 Eli Lilly shares in Q2 2026, an estimated $4.83M.
- Walleye Trading first reported a position in Eli Lilly in Q2 2013 and held it in 23 quarters.
- Walleye Trading's Eli Lilly position peaked at $107M in Q3 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.